Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Rigel Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€3.03
23.04.21
€3.50
23.04.22
-20.62%
24.04.22

Could be worthwhile Investment >10% per year
buy
ImmunityBio Inc.

Start price
Target price
Perf. (%)
€14.64
19.04.21
-
19.04.22
-68.10%
20.04.22

Could be very worthwhile Investment >20% year
buy
Cidara Therapeutics Inc

Start price
Target price
Perf. (%)
€1.78
19.04.21
-
19.04.22
-58.32%
20.04.22

Could be very worthwhile Investment >20% year
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€16.30
06.04.22
€4.00
06.04.23
-13.48%
18.04.22

Little Investments for future growth
No Innovation
Significant cyclical dependencies
Very bad culture
Clovis Oncology Inc.

Start price
Target price
Perf. (%)
€2.64
06.04.22
€1.00
06.04.23
-22.00%
18.04.22

Probably not worthwhile Investment
Decining EBIT margin than peer group
overvalued
Very low/no dividend yield expected
Clovis Oncology Inc.

Start price
Target price
Perf. (%)
€2.64
06.04.22
€0.000
06.04.23
-22.00%
18.04.22

Could be worthwhile Investment >10% per year
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
buy
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€15.54
07.04.22
-
07.04.23
-9.24%
18.04.22

Risky Investment
buy
Check Cap Ltd

Start price
Target price
Perf. (%)
€1.21
17.04.21
-
17.04.22
-72.17%
18.04.22

Could be very worthwhile Investment >20% year
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€46.84
04.04.22
€55.00
04.04.23
2.48%
16.04.22

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€46.84
04.04.22
€55.00
04.04.23
2.48%
16.04.22

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
buy
BeiGene Ltd ADR

Start price
Target price
Perf. (%)
€184.00
02.04.22
€200.00
02.04.23
-15.22%
16.04.22

Could be worthwhile Investment >10% per year
Top 10 in its market
Small cyclical dependencies
Future proof or reliable business model
buy
Cidara Therapeutics Inc

Start price
Target price
Perf. (%)
€1.83
13.04.21
-
13.04.22
-60.43%
14.04.22

Revenue growth >5% per year expected
Probably not worthwhile Investment
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
buy
Inovio Pharma

Start price
Target price
Perf. (%)
€6.45
27.11.21
€3.30
27.11.22
-52.69%
12.04.22

Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€145.98
11.11.21
€75.00
11.11.22
-63.74%
11.04.22

Very low/no dividend yield expected
very negative Cash Flow expected
ROE lower than 10% per year
high free float
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€21.16
28.03.22
-
28.03.23
-9.86%
02.04.22

Risky Investment
Lipocine Inc.

Start price
Target price
Perf. (%)
€28.44
29.03.22
-
29.03.23
-28.90%
02.04.22

Risky Investment
Lipocine Inc.

Start price
Target price
Perf. (%)
€25.25
21.03.22
€0.000
21.03.23
-19.90%
02.04.22

Below average Management
high free float
High risks for its business
Unknown brand
Kineta Inc.

Start price
Target price
Perf. (%)
€12.46
24.03.22
-
24.03.23
-23.03%
02.04.22

Probably not worthwhile Investment
buy
MorphoSys AG

Start price
Target price
Perf. (%)
€24.31
01.03.22
€30.00
01.04.22
4.07%
02.04.22

Could be worthwhile Investment >10% per year
buy
MorphoSys AG

Start price
Target price
Perf. (%)
€24.31
01.03.22
€30.00
01.04.22
4.07%
02.04.22

Could be worthwhile Investment >10% per year
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€48.26
23.03.22
€55.00
23.03.23
-3.61%
02.04.22

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€48.26
23.03.22
€55.00
23.03.23
-3.61%
02.04.22

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
buy
Bayer AG

Start price
Target price
Perf. (%)
€61.54
30.03.22
-
30.03.23
1.93%
01.04.22

buy
Bayer AG

Start price
Target price
Perf. (%)
€61.54
30.03.22
-
30.03.23
1.93%
01.04.22

buy
Valneva SE

Start price
Target price
Perf. (%)
€28.30
27.11.21
€28.00
27.11.22
-44.88%
30.03.22

Could be worthwhile Investment >10% per year
Very valuable balance sheet